http://orcid.org/0000-0002-2908-0468
Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Alex J. Krotulski, Brittany P. Chapman, Sarah J. Marks, Sam T. Ontiveros, Katharine Devin-Holcombe, Melissa F. Fogarty, Hai Trieu, Barry K. Logan, Roland C. Merchant & Kavita M. Babu. (2022) Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose. Clinical Toxicology 60:2, pages 197-204.
Read now
Read now
Javier A. Tamargo$suffix/text()$suffix/text(), Adriana Campa$suffix/text()$suffix/text(), Sabrina S. Martinez$suffix/text()$suffix/text(), Tan Li, Kenneth E. Sherman$suffix/text()$suffix/text(), Gustavo Zarini$suffix/text()$suffix/text(), Christina S. Meade$suffix/text()$suffix/text(), Raul N. Mandler$suffix/text()$suffix/text() & Marianna K. Baum$suffix/text()$suffix/text(). (2021) Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies on HIV (MASH) Cohort. Journal of Psychoactive Drugs 53:3, pages 215-223.
Read now
Read now
H. Bach, V. Jenkins, A. Aledhaim, S. Moayedi, S. M. Schenkel & H. K. Kim. (2020) Prevalence of fentanyl exposure and knowledge regarding the risk of its use among emergency department patients with active opioid use history at an urban medical center in Baltimore, Maryland. Clinical Toxicology 58:6, pages 460-465.
Read now
Read now
Sarah G. Mahonski, James B. Leonard, J. David Gatz, Hyunuk Seung, Erin E. Haas & Hong K. Kim. (2020) Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data. Clinical Toxicology 58:2, pages 117-123.
Read now
Read now
Evan Stuart Bradley, David Liss, Stephanie Pepper Carreiro, David Eric Brush & Kavita Babu. (2019) Potential uses of naltrexone in emergency department patients with opioid use disorder. Clinical Toxicology 57:9, pages 753-759.
Read now
Read now
Hong K. Kim, Nicholas J. Connors & Maryann E. Mazer-Amirshahi. (2019) The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs. Expert Opinion on Drug Safety 18:6, pages 465-475.
Read now
Read now
Prun Bijral, Karen P. Hayhurst, Sheila M. Bird & Tim Millar. (2019) Prevalence of recent fentanyl use among treated users of illicit opioids in England: based on piloted urine drug screens. Clinical Toxicology 57:5, pages 368-371.
Read now
Read now
Olaf H. Drummer. (2019) Fatalities caused by novel opioids: a review. Forensic Sciences Research 4:2, pages 95-110.
Read now
Read now
Joseph J. Palamar, Alberto Salomone, Rachele Bigiarini, Marco Vincenti, Patricia Acosta & Babak Tofighi. (2019) Testing hair for fentanyl exposure: a method to inform harm reduction behavior among individuals who use heroin. The American Journal of Drug and Alcohol Abuse 45:1, pages 90-96.
Read now
Read now
Jessica L. Moreno, Matthew S. Duprey, Bryan D. Hayes, Kirsten Brooks, Sabrina Khalil, Sarah E. Wakeman, Russell J. Roberts, Jared S. Jacobson & John W. Devlin. (2019) Agreement between self-reported psychoactive substance use and urine toxicology results for adults with opioid use disorder admitted to hospital. Toxicology Communications 3:1, pages 94-101.
Read now
Read now
Articles from other publishers (22)
Damiana Cavallo, Eamonn Kelly, Graeme Henderson & Ana Paula Abdala Sheikh. (2023) Comparison of the effects of fentanyls and other μ opioid receptor agonists on the electrical activity of respiratory muscles in the rat. Frontiers in Pharmacology 14.
Crossref
Crossref
Dwaipayan Mukherjee, Michelle Collins, Douglas E. Dylla, Jatinder Kaur, Dimitri Semizarov, Anthony Martinez, Brian Conway, Tipu Khan & Nael M. Mostafa. (2023) Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations. Infectious Diseases and Therapy.
Crossref
Crossref
Raminta Daniulaityte, Lance Ruhter, Matthew Juhascik & Sydney Silverstein. (2023) Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs. Harm Reduction Journal 20:1.
Crossref
Crossref
Jessica Duncan Cance, Amanda Bingaman, Heather Kane, Sara Hairgrove, Sorina B. Torrez, Austin Buck, Claire M. Zagorski, Lindsey J. Loera & Lucas G. Hill. (2023) A qualitative exploration of unintentional versus intentional exposure to fentanyl among people who use drugs in Austin, TX. Journal of the American Pharmacists Association 63:1, pages 317-323.
Crossref
Crossref
Jayashree C. Patel & Suphiya Parveen. (2021) In Vitro and In Vivo Analysis of Fentanyl and Fentalog Metabolites using Hyphenated Chromatographic Techniques: A Review. Chemical Research in Toxicology 35:1, pages 30-42.
Crossref
Crossref
Sarah E. Duhart Clarke, Alex H. Kral & Jon E. Zibbell. (2022) Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market. International Journal of Drug Policy 99, pages 103467.
Crossref
Crossref
Roy R. Gerona & Deborah French. 2022.
217
263
.
Xinyi Jiang, Gery P. Guy Jr.Christopher Dunphy, Cassandra M. Pickens & Christopher M. Jones. (2021) Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019. Drug and Alcohol Dependence 229, pages 109160.
Crossref
Crossref
Pietro Brunetti, Filippo Pirani, Jeremy Carlier, Raffaele Giorgetti, Francesco Paolo Busardò & Alfredo Fabrizio Lo Faro. (2021) A 2017–2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs. Journal of Analytical Toxicology 45:6, pages 537-554.
Crossref
Crossref
Jon E. Zibbell, Nicholas C. Peiper, Sarah E. Duhart Clarke, Zach R. Salazar, Louise B. Vincent, Alex H. Kral & Judith Feinberg. (2021) Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina. International Journal of Drug Policy 93, pages 103128.
Crossref
Crossref
Anna Kline, Dina Mattern, Nina Cooperman, Jill M. Williams, Patricia Dooley-Budsock, Ralph Foglia & Suzanne Borys. (2021) Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors. International Journal of Drug Policy 90, pages 103051.
Crossref
Crossref
Richard J. Bodnar. (2020) Endogenous Opiates and Behavior: 2018. Peptides 132, pages 170348.
Crossref
Crossref
Sanjana Mitra, Jade Boyd, Evan Wood, Cameron Grant, M.-.J. Milloy, Kora DeBeck, Thomas Kerr & Kanna Hayashi. (2020) Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: A cross-sectional analysis. International Journal of Drug Policy 83, pages 102864.
Crossref
Crossref
Elodie Lefrancois, Vendula Belackova, Edmund Silins, Julie Latimer, Marianne Jauncey, Ronald Shimmon, Dayanne Mozaner Bordin, Marc Augsburger, Pierre Esseiva, Claude Roux & Marie Morelato. (2020) Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type. Drug and Alcohol Dependence 209, pages 107909.
Crossref
Crossref
Andrea Meier, Sarah K. Moore, Elizabeth C. Saunders, Bethany McLeman, Stephen A. Metcalf, Samantha Auty, Olivia Walsh & Lisa A. Marsch. (2020) Understanding the increase in opioid overdoses in New Hampshire: A rapid epidemiologic assessment. Drug and Alcohol Dependence 209, pages 107893.
Crossref
Crossref
Rob Hill, Rakulan Santhakumar, William Dewey, Eamonn Kelly & Graeme Henderson. (2019) Fentanyl depression of respiration: Comparison with heroin and morphine. British Journal of Pharmacology 177:2, pages 254-265.
Crossref
Crossref
George Sam Wang & Christopher Hoyte. (2019) Novel Drugs of Abuse. Pediatrics In Review 40:2, pages 71-78.
Crossref
Crossref
Jaclyn Blachman-ForshayMichelle L. NolanJonathan M. McAteerDenise Paone. (2018) Estimating the Risk of Exposure to Fentanyl in New York City: Testing Drug Residue in Used Syringes. American Journal of Public Health 108:12, pages 1666-1668.
Crossref
Crossref
Maxwell S. Krieger, William C. Goedel, Jane A. Buxton, Mark Lysyshyn, Edward Bernstein, Susan G. Sherman, Josiah D. Rich, Scott E. Hadland, Traci C. Green & Brandon D.L. Marshall. (2018) Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy 61, pages 52-58.
Crossref
Crossref
Katarzyna Kuczyńska, Piotr Grzonkowski, Łukasz Kacprzak & Jolanta B. Zawilska. (2018) Abuse of fentanyl: An emerging problem to face. Forensic Science International 289, pages 207-214.
Crossref
Crossref
Tess M. Kilwein, Preston Hunt & Alison Looby. (2018) A Descriptive Examination of Nonmedical Fentanyl Use in the United States: Characteristics of Use, Motives, and Consequences. Journal of Drug Issues 48:3, pages 409-420.
Crossref
Crossref
Matthew K. Griswold, Brittany P. Chapman, Alex J. Krotulski, Melissa Friscia, Edward W. Boyer, Barry K. Logan & Kavita M. Babu. (2018) Cryptomarket drug acquisition leading to furanyl fentanyl overdose. Forensic Toxicology 36:2, pages 534-536.
Crossref
Crossref